EX-10.23 15 filename15.htmTechnology Transfer and Supply Agreement • May 5th, 2020 • New York
Contract Type FiledMay 5th, 2020 JurisdictionConfidential ***Text Omitted and Filed Separately with the Securities and Exchange Commission. Confidential Treatment Requested Under 17 C.F.R. Sections 200.80(b)(4) and 240.24b-2.
TECHNOLOGY TRANSFER AND SUPPLY AGREEMENT BETWEEN: Sophiris Bio Corp. (Formerly Protox Therapeutics Corp.) California USA (hereinafter referred to as “Sophiris”) and Boehringer Ingelheim RCV GmbH & Co KG Dr. Boehringer Gasse 5-11 (hereinafter referred...Technology Transfer and Supply Agreement • January 22nd, 2013 • Sophiris Bio Inc. • Pharmaceutical preparations • New York
Contract Type FiledJanuary 22nd, 2013 Company Industry JurisdictionWHEREAS, BI RCV and its Affiliate BIP (as defined below) own facilities specialised for GMP manufacture of biopharmaceuticals and employ personnel who have experience in process development, the production, quality control as well as in the registration of biopharmaceuticals for clinical trials and commercial sale in the United States, Europe and elsewhere; and